Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Nivolumab + Axitinib for Kidney Cancer
Recruiting1 awardPhase 1 & 2
Philadelphia, Pennsylvania
This trial is testing a combination of drugs to treat advanced renal cell carcinoma in both previously treated and untreated patients. The first part of the trial will establish a safe and tolerable dose, and the second part will test the efficacy of the combination at that dose.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.